Secondly, a recent study found that MDSCs-derived IL-1β was involved in CRC chemoresistance (45), indicating the heterogeneity and necessity of epigenetic profiling for individualized diagnosis and treatment of cancer. The gene discussed is IL1B; the disease is colorectal carcinoma.